Massachusetts-based biotechnology company Advanced Cell Technology Inc.(ACTC) Dec. 23 agreed to settle Securities and Exchange Commission allegations it issued unregistered shares on 13 different occasions without qualifying for a registration exemption (SEC v. Lefkowitz).
The proposed settlement, subject to approval by the U.S. District Court for the Middle District of Florida, would enjoin Advanced Cell from future violations of the 1933
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.